Skip to search boxSkip to navigationSkip to main content

Quinolone-resistance mutations in the topoisomerase IV parC gene of Acinetobacter baumannii

  • Jordi Vila(corresponding author)
    ,
  • ,
  • Pilar Goñi
    ,
  • Teresa Jimenez De Anta
*Corresponding author for this work
Research Output:
Contribution to journal
Article
Peer-review

Open access

Publication Information

Output type

Research Output:
Contribution to journal
Article
Peer-review

Original language

English

Pages from-to (Number of pages)

Pages 757-762 (6 pages)

Journal (Volume, Issue Number)

Journal of Antimicrobial Chemotherapy (Volume 39, Issue 6)

Publication milestones

  • Published - 1997

Publication status

Published - 1997

ISSN

0305-7453

Publication IDs

  • Scopus: 0030851997
  • PubMed: 9222045

Abstract

Mutations in the parC gene, which encodes a subunit of topoisomerase IV, were determined in 21 epidemiologically unrelated clinical isolates of Acinetobacter baumannii. Our studies highlight the conserved sequences in the quinolone-resistance-determining region of the parC gene from A. baumannii and other bacteria. Nine of ten isolates with MICs of ciprofloxacin of ≤ 32 mg/L showed a change of Ser80 to Leu and one showed a change of Glu84 to Lys. These results suggest that ParC from A. baumannii is a secondary target for quinolones and that mutations at residues Ser80 and Glu84, when combined with mutations at Ser83 of GyrA, may render A. baumannii highly resistant to quinolones.

Publication metrics

Metrics

Scopus
Citations

PlumX, opens in new tab

Citations
163
Captures
73

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well